Intellia Therapeutics (NTLA) PT Lowered to $70 at Oppenheimer
Tweet
Share
E-mailGet Alerts NTLA Hot Sheet
Price: $12.09 +1.51%
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Oppenheimer analyst Jay Olson lowered the price target on Intellia Therapeutics (NASDAQ: NTLA) to $70.00 (from $80.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Info Edge India (INFOE:IN) PT Raised to INR1,260 at Macquarie
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
